The tear cytokine profile in patients with active Graves’ orbitopathy

Morgan Yang, Yvonne Chung, Stephanie Lang, Nobuyo Yawata, Lay Leng Seah, Audrey Looi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: The primary aim of this study is to isolate cytokines specific for active Graves’ orbitopathy (GO) in the tears of affected patients. The secondary aim is to identify other cytokines of interest and to look at the profile of their levels over time. Methods: This is a prospective pilot study conducted at the Singapore National Eye Centre. A total of 10 patients with active GO and 10 patients from each of 3 control groups were recruited. The 3 control groups were the following: age-matched normal female patients, patients with GO who were clinically inactive and patients with bilateral viral conjunctivitis. Tears from patients from the control groups were collected on a single visit. For patients with active GO, tears were collected on presentation, at 6 months, 12 months and 18 months. Results: Of all the cytokines examined, only IL-7 yielded a difference when the concentration in patients with active GO was compared with concentrations in all the control groups. This difference was most significant at the 18-month follow-up visit. Conclusions: Low concentrations of IL-7 in tears exhibit specificity for active GO in patients nearly 2 years from the clinical onset of activity. Although using IL-7 in tears as a biomarker for disease activity may be limited due to its late manifestation, targeting immune restitution using IL-7 may have disease modifying effects.

Original languageEnglish
Pages (from-to)402-409
Number of pages8
JournalEndocrine
Volume59
Issue number2
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Tears
Cytokines
Interleukin-7
Control Groups
Viral Conjunctivitis
Singapore
Biomarkers
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The tear cytokine profile in patients with active Graves’ orbitopathy. / Yang, Morgan; Chung, Yvonne; Lang, Stephanie; Yawata, Nobuyo; Seah, Lay Leng; Looi, Audrey.

In: Endocrine, Vol. 59, No. 2, 01.02.2018, p. 402-409.

Research output: Contribution to journalArticle

Yang, M, Chung, Y, Lang, S, Yawata, N, Seah, LL & Looi, A 2018, 'The tear cytokine profile in patients with active Graves’ orbitopathy', Endocrine, vol. 59, no. 2, pp. 402-409. https://doi.org/10.1007/s12020-017-1467-2
Yang, Morgan ; Chung, Yvonne ; Lang, Stephanie ; Yawata, Nobuyo ; Seah, Lay Leng ; Looi, Audrey. / The tear cytokine profile in patients with active Graves’ orbitopathy. In: Endocrine. 2018 ; Vol. 59, No. 2. pp. 402-409.
@article{1b192caf9f0440c3878cd2f9d299de5f,
title = "The tear cytokine profile in patients with active Graves’ orbitopathy",
abstract = "Purpose: The primary aim of this study is to isolate cytokines specific for active Graves’ orbitopathy (GO) in the tears of affected patients. The secondary aim is to identify other cytokines of interest and to look at the profile of their levels over time. Methods: This is a prospective pilot study conducted at the Singapore National Eye Centre. A total of 10 patients with active GO and 10 patients from each of 3 control groups were recruited. The 3 control groups were the following: age-matched normal female patients, patients with GO who were clinically inactive and patients with bilateral viral conjunctivitis. Tears from patients from the control groups were collected on a single visit. For patients with active GO, tears were collected on presentation, at 6 months, 12 months and 18 months. Results: Of all the cytokines examined, only IL-7 yielded a difference when the concentration in patients with active GO was compared with concentrations in all the control groups. This difference was most significant at the 18-month follow-up visit. Conclusions: Low concentrations of IL-7 in tears exhibit specificity for active GO in patients nearly 2 years from the clinical onset of activity. Although using IL-7 in tears as a biomarker for disease activity may be limited due to its late manifestation, targeting immune restitution using IL-7 may have disease modifying effects.",
author = "Morgan Yang and Yvonne Chung and Stephanie Lang and Nobuyo Yawata and Seah, {Lay Leng} and Audrey Looi",
year = "2018",
month = "2",
day = "1",
doi = "10.1007/s12020-017-1467-2",
language = "English",
volume = "59",
pages = "402--409",
journal = "Endocrine",
issn = "0969-711X",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - The tear cytokine profile in patients with active Graves’ orbitopathy

AU - Yang, Morgan

AU - Chung, Yvonne

AU - Lang, Stephanie

AU - Yawata, Nobuyo

AU - Seah, Lay Leng

AU - Looi, Audrey

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Purpose: The primary aim of this study is to isolate cytokines specific for active Graves’ orbitopathy (GO) in the tears of affected patients. The secondary aim is to identify other cytokines of interest and to look at the profile of their levels over time. Methods: This is a prospective pilot study conducted at the Singapore National Eye Centre. A total of 10 patients with active GO and 10 patients from each of 3 control groups were recruited. The 3 control groups were the following: age-matched normal female patients, patients with GO who were clinically inactive and patients with bilateral viral conjunctivitis. Tears from patients from the control groups were collected on a single visit. For patients with active GO, tears were collected on presentation, at 6 months, 12 months and 18 months. Results: Of all the cytokines examined, only IL-7 yielded a difference when the concentration in patients with active GO was compared with concentrations in all the control groups. This difference was most significant at the 18-month follow-up visit. Conclusions: Low concentrations of IL-7 in tears exhibit specificity for active GO in patients nearly 2 years from the clinical onset of activity. Although using IL-7 in tears as a biomarker for disease activity may be limited due to its late manifestation, targeting immune restitution using IL-7 may have disease modifying effects.

AB - Purpose: The primary aim of this study is to isolate cytokines specific for active Graves’ orbitopathy (GO) in the tears of affected patients. The secondary aim is to identify other cytokines of interest and to look at the profile of their levels over time. Methods: This is a prospective pilot study conducted at the Singapore National Eye Centre. A total of 10 patients with active GO and 10 patients from each of 3 control groups were recruited. The 3 control groups were the following: age-matched normal female patients, patients with GO who were clinically inactive and patients with bilateral viral conjunctivitis. Tears from patients from the control groups were collected on a single visit. For patients with active GO, tears were collected on presentation, at 6 months, 12 months and 18 months. Results: Of all the cytokines examined, only IL-7 yielded a difference when the concentration in patients with active GO was compared with concentrations in all the control groups. This difference was most significant at the 18-month follow-up visit. Conclusions: Low concentrations of IL-7 in tears exhibit specificity for active GO in patients nearly 2 years from the clinical onset of activity. Although using IL-7 in tears as a biomarker for disease activity may be limited due to its late manifestation, targeting immune restitution using IL-7 may have disease modifying effects.

UR - http://www.scopus.com/inward/record.url?scp=85034258077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034258077&partnerID=8YFLogxK

U2 - 10.1007/s12020-017-1467-2

DO - 10.1007/s12020-017-1467-2

M3 - Article

VL - 59

SP - 402

EP - 409

JO - Endocrine

JF - Endocrine

SN - 0969-711X

IS - 2

ER -